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Abstract
Background: High resolution μCT, and combined μPET/CT have emerged as non-invasive techniques to enhance
or even replace dual energy X-ray absorptiometry (DXA) as the current preferred approach for fragility fracture risk
assessment. The aim of this study was to assess the ability of µPET/CT imaging to differentiate changes in rat bone
tissue  density  and  microstructure  induced  by  metabolic  bone  diseases  more  accurately  than  current  available
methods.
Methods: Thirty three rats were divided into three groups of control, ovariectomy and vitamin-D deficiency. At the
conclusion of the study, animals were subjected to glucose (18FDG) and sodium fluoride (Na18F) PET/CT scanning.
Then, specimens were subjected to µCT imaging and tensile mechanical testing.
Results: Compared to control, those allocated to ovariectomy and vitamin D deficiency groups showed 4% and 22%
(significant)  increase  in  18FDG  uptake  values,  respectively.  DXA-based  bone  mineral  density  was  higher  in  the
vitamin D deficiency group when compared to the other groups (cortical bone), yet μCT-based apparent and mineral
density results were not different between groups. DXA-based bone mineral density was lower in the ovariectomy
group  when  compared  to  the  other  groups  (cancellous  bone);  yet  μCT-based  mineral  density  results  were  not
different  between  groups,  and  the  μCT-based  apparent  density  results  were  lower  in  the  ovariectomy  group
compared to the other groups.
Conclusion: PET and micro-CT provide an accurate three-dimensional measurement of the changes in bone tissue
mineral density, as well as microstructure for cortical and cancellous bone and metabolic activity. As osteomalacia is
characterized by impaired bone mineralization, the use of densitometric analyses may lead to misinterpretation of the
condition as osteoporosis. In contrast, µCT alone and in combination with the PET component certainly provides an
accurate  three-dimensional  measurement  of  the  changes  in  both  bone  tissue  mineral  density,  as  well  as
microstructure for cortical and cancellous bone and metabolic activity.
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Introduction
Fragility  fractures  occurring  at  multiple  skeletal  sites  affect
approximately  1.5  million  in  the  United  States  annually  [1],
where four out of ten white women aged 50 or older will suffer
a fracture due to osteoporosis. Most commonly involved sites
include  the  spine,  the  distal  forearm  and  the  hip  [2,3].  The
projected  increase  of  the  elderly  population  will  most  likely
increase  in  number  of  fractures  following  falls  in  those  at
greater risk [4]. Fragility fractures in osteoporosis are caused
by low bone mass and micro-architectural deterioration of bone
tissue [5]. The World Health Organization identifies individuals
at risk for these types of fractures based on their areal bone
mineral  density  (aBMD)  measured  by  dual  energy  X-ray
absorptiometry  (DXA)  at  the  hip,  lumbar  spine  or  forearm,
compared  to  normal  reference  values  [6].  However,  such
aBMD-based  fracture  predictions  have  been  shown  to  lack
sensitivity and specificity [7-11].
PLOS ONE | www.plosone.org 1 December 2013 | Volume 8 | Issue 12 | e82709While  osteoporosis  is  assumed  to  be  the  cause  of  most
fragility fractures, 25-OH-vitamin D deficiency (a condition not
distinguished by densitometric measurements), is observed in
more  than  half  of  postmenopausal  women  receiving
osteoporosis  therapy  [12].  Vitamin  D  deficiency  results  in
osteomalacia in adults. A positive association has been found
between  25-OH-vitamin  D  levels  and  total  hip  aBMD;  and
correspondingly,  lower  concentrations  of  this  mineral  have
been  reported  in  patients  who  sustained  hip  fractures,
compared with controls [13,14]. Additionally, typical histological
changes seen in osteomalacia were found in 25% of patients
with femoral head fractures [15]. The increased local rate of
bone  turnover  translates  in  decrements  in  aBMD  and  bone
mineral  content,  changes  that  are  more  pronounced  in
cancellous bone [16]. Although it has been stated that aBMD
values  are  not  necessary  for  the  diagnosis  of  osteomalacia,
their serial measurement following initiation of treatment makes
it  a  valuable  tool.  It  has  been  shown  that  clinical  and
biochemical  improvement  ensues  somewhat  rapidly,  while
bone mineral deficit takes longer to correct.
As they may coexist, we find relevant to establish significant
biochemical  and  structural  differences  between  osteoporosis
and  osteomalacia,  as  a  means  to  provide  better  treatment
options  for  each  pathologic  condition.  The  former  is
characterized by a loss of the integrity of the trabecular network
and  the  cortical  shell,  resulting  in  overall  reduction  in  bone
strength [17]. In contrast, osteomalacia results due to a failure
of  the  osteoid  to  calcify  as  it  is  laid  down,  leading  to  an
increased  osteoid  surface  and  width,  and  decreased
mineralizing  surfaces  [18].  While  both  conditions  lead  to
alterations in bone structure and strength, osteoporosis occurs
with  relatively  normal  bone  tissue  density  (bone  mass/bone
tissue  volume,  g.cm-3)  and  a  significant  decrease  in  bone
volume  fraction  (bone  tissue  volume/total  specimen  volume,
mm3/mm3). In contrast, osteomalacia presents with a significant
decrease  in  bone  tissue  density  and  a  less  pronounced
decrease in volume fraction [19].
There  are  limitations  associated  with  current  diagnostic
methods to differentiate between metabolic bone diseases that
alter the mineral and structural states of cortical and cancellous
bones through different mechanisms. In a previous study, we
used  several  surrogate  rat  models  to  mimic  altered  skeletal
states and showed the inability of DXA to differentiate changes
occurring in bone microstructure or density [19]. In that study
we  highlighted  the  advantages  of  using  volumetric  methods,
such as quantitative computed tomography (QCT), to provide
an  accurate  assessment  of  changes  in  both  bone  mineral
density and microstructure occurring in cortical and cancellous
bone. However, although QCT provides more information than
DXA, it still does not yield details regarding bone biology and
its  interaction  with  the  tissue’s  architecture  and  material
properties.  Getting  such  information  gains  more  relevance
when  diagnosing  and  addressing  the  consequences  of
common  metabolic  conditions  that  compromise  the  normal
skeletal homeostasis.
High-resolution  liquid/solid  state  magnetic  resonance
imaging  (MRI)  and  combined  positron  emission  tomography
(PET) and CT imaging can potentially assess bone biology and
architecture.  PET  is  a  well-established,  non-invasive  imaging
modality  that  evaluates  metabolic  activity  through  uptake  of
radioactive tracers in tissue. Historically, clinical PET and CT
scanners  have  been  hindered  by  low-resolution.  The
development  of  high-resolution  scanners  that  combine  both
imaging modalities have recently allowed the critical study of
bone.  These  novel  techniques  are  providing  a  great  deal  of
information  related  to  the  physiological  and  architectural
responses of bone to aging and treatment. Furthermore, the
expanding clinical usage of PET/CT has recently increased the
interest  of  using  18F-fluoride  PET/CT  for  bone  imaging  [20].
This ion has been widely recognized for its ability to deposit in
bone,  preferentially  at  the  sites  of  high  osteoblastic  activity
related to bone remodeling [21,22].
More  recently,  three-dimensional  high-resolution  peripheral
quantitative  computed  tomography  (HR-pQCT)  provides  the
ability to similarly measure components of bone quality such as
BMD,  micro-architectural  morphology  and  bone  mechanics.
The  increased  spatial  resolution  underscores  its  clinical
importance, allowing the in vivo assessment of bone quality, a
well-known limitation of currently used techniques [23,24].
The ovariectomized rat model has been widely used to study
the  effects  of  menopause  on  bone  mass,  trabecular
microstructure and fracture risk [25-30]. Similarly, the chronic
vitamin D deficient diet rat model has been used to assess the
burden of osteomalacia on bone metabolism [29,31]. We used
the established ovariectomy model in the present study as a
surrogate  for  osteopenia,  in  conjunction  with  the  vitamin  D
deficient  diet  model  as  a  surrogate  for  osteomalacia.  Both
models  aim  to  induce  altered  states  of  bone  mineralization/
microarchitecture  to  enable  us  to  study  the  performance  of
combined PET/CT imaging to assess changes in bone tissue
density  and  microstructure,  as  compared  to  current  gold
standard  techniques  of  DXA,  as  well  as  high-resolution  CT
imaging, and mechanical testing.
To  this  end,  we  hypothesize  that  µPET/CT  imaging  is
capable of assessing changes in rat bone tissue density and
microstructure  induced  by  metabolic  bone  diseases  more
accurately than current available methods. By providing a more
detailed  analysis,  information  obtained  from  this  approach
could ultimately lead to better bone quality assessment as well
as accurate non-invasive diagnosis of specific metabolic bone
diseases.
Materials and Methods
Animal Models
Thirty  three  female  Sprague  Dawley  rats  (11  weeks  old,
mass:  200-225  grams)  were  obtained  from  Charles  River
Laboratories  (Charles  River,  Charlestown,  MA,  USA)  and
divided  into  three  equally  sized  groups.  The  animals  in  the
control  group  (CON)  were  not  subjected  to  any  surgical  or
dietary interventions. The animals allocated to the OVX group
underwent ovariectomy to induce a state of low bone mass and
micro-architectural deterioration. Finally, the animals assigned
to  the  vitamin  D  deficient  VIT-D  group  were  placed  on  a
modified  diet  to  induce  inadequate  bone  mineralization.  The
ovariectomy procedure was conducted at the animal supplier
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laboratory.  The  vitamin  D  deficient  diet  consisted  of  0.4%
calcium and 0% vitamin D (modified Basal Diet 5755, TestDiet,
Richmond,  IN,  USA).  All  animals  underwent  monthly
measurement  of  bone  mineral  content  and  density  via  DXA.
They  were  also  weighted  in  the  same  interval  to  assess
changes in body mass over the study period. At the conclusion
of  the  study  period  (4  months  following  arrival  at  our
laboratory),  the  animals  were  subjected  to  18fluoro-2-
deoxyglucose  (FDG)  and  Na18F  PET/CT  scanning.  Following
the  image  acquisition  protocol,  all  rats  were  euthanized  by
means  of  CO2  gas  inhalation.  Femurs  were  excised  and
cleaned  from  adherent  soft  tissue.  One  femur  from  each
animal, selected at random, was subjected to micro-CT (µCT)
imaging  and  later  underwent  destructive  mechanical  testing
(Figure  1).  The  study  protocol  was  approved  by  Beth  Israel
Deaconess Medical Center’s Institutional Animal Care and Use
Committee (IACUC).
In-vivo Dual Energy X-ray Absorptiometry (DXA)
Areal bone mineral density (aBMD, g.cm-2) and bone mineral
content (BMC, g) were measured from the femoral diaphysis
(cortical bone) and distal metaphysis (cancellous bone) on a
monthly basis over a four-month period. Measurements were
conducted using a pre-clinical DXA system (Lunar PIXImus2,
General Electric, Waukesha, WI, USA). Two landmark-based
analysis boxes, one to cover the cortical bone area and the
other  to  cover  the  distal  femoral  metaphysis,  were  used  to
assess aBMD and BMC throughout the study.
In-vivo Micro Positron-emission Tomography/
Computed Tomography (µPET/CT)
µPET/CT scanning was performed on five animals per group
using  a  mosaic  high  performance  µPET  (Philips,  Cleveland,
OH, USA) in conjunction with the µCT component of a nano-
SPECT/CT  system  (Bioscan,  Washington  DC,  USA).  The
µPET  system  achieves  a  1.9  mm  full-width  half-maximum
(FWHM) spatial resolution and an 11.9 cm axial field-of-view.
Rapid  reconstruction  of  the  final  three-dimensional  data  set
was performed on the Imalytics Workspace (Philips, Cleveland,
OH, USA) for high throughput and quantitative data analysis.
Animals were scanned over a two-day period, with 18FDG PET
Figure  1.    Study  time-line  highlighting  surgical
procedure and measurements.  
doi: 10.1371/journal.pone.0082709.g001
and CT imaging (450 µm voxel size) conducted on day one,
followed by Na18F PET imaging on day two. Bone density was
assessed using water and air signals for calibration. One femur
from each animal was contoured to assess the percentages of
18FDG and Na18F uptake in a specific anatomic location.
Ex-vivo Micro-computed Tomographic Imaging (µCT)
and Image Analysis
Sequential transaxial images through the entire diaphyseal
cortical  and  metaphyseal  trabecular  sections  of  the  femurs
were obtained using µCT at an isotropic voxel size of 30 µm,
integration time of 250 ms, tube voltage and current of 55 KVp
and  145  µA  respectively,  while  applying  a  1200  mg.cm-3
hydroxyapatite  beam  hardening  correction  (µCT  40,  Scanco
Medical AG, Brüttisellen, Switzerland).
Images  were  binarized  to  separate  bone  from  background
using an established adapting thresholding procedure [32]. A
three-dimensional Gaussian filter (σ = 0.8) with a limited, finite
filter support (support = 1) was used to suppress the noise in
the volumes. In this technique, the optimal threshold is chosen
automatically  as  a  result  of  an  iterative  process,  where
successive  iterations  provide  increasingly  cleaner  extractions
of the object region.
After thresholding, the following parameters were assessed
for all images [33]. Cortical bone volume fraction (Ct.BV/TV);
cortical  thickness  (Ct.Th),  along  with  direct  trabecular
morphometric indices of bone volume fraction (BV/TV); bone
surface  density  (BS/BV);  structure  model  index  (SMI);
trabecular  number  (Tb.N);  trabecular  thickness  (Tb.Th)  and
spacing  (Tb.Sp),  each  with  its  intra-individual  standard
deviation (Tb.Th SD and Tb.Sp SD, respectively), calculated as
the second moment of each’s histogram distribution; degree of
anisotropy, defined as the longest divided by the shortest mean
intercept  length  (DA);  and  connectivity  density  (Conn.D).
Additionally,  cortical  and  cancellous  volumetric  bone  mineral
density (σMIN, g.cm-3) and apparent bone density (σAPP, g.cm-3)
were measured using a hydroxyapatite phantom, supplied by
the manufacturer, to convert the X-ray attenuation coefficient
(µ)  to  mineral  density.  The  variability  of  µCT  assessment  of
three-dimensional microstructural and densitometric indices of
excised rat bone samples is less than 0.5% at our laboratory.
Ex-vivo Tensile Mechanical Testing
Following the µCT imaging, both ends of the femurs were
embedded  in  polymethylmethacrylate  to  provide  adequate
gripping surfaces for mechanical testing. A stress riser notch
was placed at the mid-diaphysis of each femur with markers
placed at each side used as reference points for the camera to
be able to assess mid-axis strain during testing. The prepped
femur  was  mounted  into  a  previously  described  tensile
apparatus  [34]  and  was  loaded  to  failure  at  a  strain  rate  of
0.005 s-1 (Synergy 200, MTS Systems, Eden Prairie, MN, USA)
(Figure 2). A digital camera, which was previously calibrated
with a calibration glass, (PixeLINK CMOS microscopy camera
model PL-B681C, Ottawa, ON, Canada) captured images at a
rate  of  20  frames/s  throughout  testing.  A  Matlab  program
(MATLAB  v12.0,  Mathworks,  Natick,  MA,  USA)  was  used  to
determine the mid-axis strain by measuring the differences in
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(positioned above and below the stress riser notch). The cross-
sectional area of bone for each slice was calculated from the
µCT  images  by  counting  the  number  of  bone  voxels  and
multiplying  by  pixel  size.  In  cortical  bones,  the  cross-section
with the minimum bony area was used to calculate the tensile
strength. Additionally, extrinsic tensile properties of the cortical
component of the femurs, such as tensile modulus (E, MPa),
ultimate  strain  (εULT,  mm/mm),  ultimate  strength  (σULT,  MPa),
and  energy  to  failure  (Energy,  J)  were  calculated  for  all
specimens.
Statistical Analysis
Normality  of  continuous  data  was  assessed  using  the
Kolmogorov-Smirnov  test.  Power  analysis  indicated  that  a
sample  size  of  11  animals  randomized  to  each  of  the  three
groups would provide 80% power to detect a 10% difference in
FDG uptake (assuming a standard deviation of 6%, effect size
= 1.67) using the F-test in ANOVA  with a two-tailed Bonferroni-
corrected  p  <  0.05  (nQuery  Advisor,  Statistical  Solutions,
Saugus,  MA).  Different  parameters  including  aBMD,  BMC,
body  mass,  cancellous  and  cortical  bone  microstructural
indices,  bone  tissue  density  (σBONE),  PET  18FDG,  Na18F,
PET  HU,  and  extrinsic  mechanical  properties  served  as
dependent  variables  and  were  compared  across  the  three
groups  with  the  use  of  a  one-way  analysis  of  variance  [35].
Also, a one-way ANOVA with post-hoc Bonferroni correction for
multiple comparisons was conducted with aBMD, BMC, body
mass and femur length over time as dependent variables.
Data  analysis  was  performed  on  the  SPSS  statistical
package  (version  19.0,  Chicago,  IL,  USA).  All  reported  p-
Figure  2.    An  illustration  of  the  tensile  testing
mechanism used in the study.  
doi: 10.1371/journal.pone.0082709.g002
values  are  two-tailed  with  p<0.05  considered  statistically
significant.
Results
The 18FDG PET imaging intent was to quantify the metabolic
activity of the bone, whereas the Na18F PET imaging aimed to
quantify the osteoblastic activity within the bone. Compared to
the  control,  those  allocated  to  the  OVX  and  VIT-D  groups
showed a relative increase of 4% (P = 0.823) and 28% (P =
0.015)  in  18FDG  uptake  values,  respectively  (Table  1  and
Figure 3). The VIT-D group exhibited an increase 17% uptake
when compared to the OVX group (P = 0.031). Additionally, the
experimental groups showed lower, yet non-significant, Na18F
uptake values when using the control group as a reference (4%
(0.0775) and 8% (P = 0.403) for OVX and VIT-D, respectively).
Bone density estimated in Hounsfield units from the PET/µCT
images  showed  that  the  CON  group  had  relatively  higher
values when compared to those in the OVX and VIT-D groups
P=0.0001  for  both  cases).  Also,  the  OVX  group  indicated
higher bone density values than the VIT-D group (P = 0.0001).
There were no differences in the DXA-based cortical BMC
values  between  the  three  study  groups;  however,  disparities
were seen in the aBMD values when comparing rats in the VIT-
D  groups  with  those  in  the  CON  and  OVX  groups  (p=0.01)
(Table 2). Regarding mechanical testing-based measurements,
cortical  bone  ultimate  strength  was  significantly  lower  in  the
OVX and VIT-D groups (p<0.01) in comparison to that of the
control.  No  differences  were  observed  in  energy  to  failure.
However, specimens from the OVX group showed lower tensile
modulus values when compared to the other two groups, only
reaching  statistical  significance  against  the  CON  group
(p<0.01).  Although  none  of  the  µCT-based  cortical  bone
parameters  reached  a  statistically  significant  difference,  this
was not the case for cancellous bone. BMC and aBMD were
significantly lower in the OVX group as compared to the other
two  groups  (p<0.001)  (Table  3).  The  OVX  group  showed
Table  1.  PET/CT  based  18FDG  and  Na18F  uptake  and
bone density values for femurs.
  PET/CT-based Measurements
Group FDG Uptake [%] NaF Uptake [%] Bone Density [HU]
CON 68.1 100 1325
Std Dev 5.3 - 24.7
OVX 70.9 95.7 1138
Std Dev 6.6 6.8 17.5
VIT-D 87.7 92.0 1090
Std Dev 5.9 8.1 13.3
P [Group] 0.013 0.433 0.0001
P*: CON-OVX 0.823 0.775 0.0001
P*: CON-VIT-D 0.015 0.403 0.0000
P*:OVX-VIT-D 0.031 0.775 0.023
P*: P values from Bonferonni post-hoc analysis
* CON NaF values were used as reference (%100) for other groups.
doi: 10.1371/journal.pone.0082709.t001
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categories  in  parameters  such  as  bone  volume  fraction,
connectivity density, trabecular number, and apparent density
(p<0.001). As for trabecular spacing, the OVX group showed
significantly higher values (p<0.001). The structure model index
was different across all three groups (p<0.05), while the degree
of  anisotropy  was  higher  in  the  CON  group  only  when
Figure  3.    CT,  PET  18FDG  and  PET  Na18F  images  from
representative animals from CON, OVX and VIT-D groups.  
doi: 10.1371/journal.pone.0082709.g003
comparing  individually  against  the  OVX  and  VIT-D  groups
(p<0.001 for both).
Over the course of the study, cortical aBMD measurements
of the two experimental groups showed an upward trend; while
the control group exhibited a fairly linear trend between time-
points  3  and  4  (Figure  4).  Cancellous  aBMD  trends
demonstrated  a  rather  linear  pattern  with  overall  subtle
decreasing changes at the end of the study period in the CON
and VIT-D groups.
All animals gained weight during the study period. Animals in
the OVX group exhibited the greatest gain, especially during
the  first  two  time  points,  where  a  dramatic  slope  was  seen.
Although no greater than the OVX group, those in the VIT-D
group  gained  more  weight  than  the  control  group  as  well
(Figure 5).
Discussion
We aimed to prove the ability of combined µPET/CT imaging
to  effectively  detect  bone  tissue  changes  in  the  presence  of
metabolic  diseases  that  promote  an  altered  skeletal  state.
Although bone turnover markers measured in serum and urine
can  aid  in  the  diagnosis  of  metabolic  bone  diseases,  bone
histomorphometry is still considered the gold standard method.
However, given the invasive nature of the procedure, novel and
reliable  non-invasive  methods  have  been  long  sought  for
diagnosing and evaluating treatment of patients affected with
these bone conditions [22]. The role of bone mass loss in the
pathophysiology  of  fragility  fractures  has  taken  most  of  the
attention; however, we now know that bone quality plays an
even  more  crucial  role.  The  concept  of  quality  comprises
multiple  aspects  that  include  material  composition  and
property,  geometry,  cellularity,  bone  turnover,  as  well  as
mineralization, microarchitecture and microdamage [36-38]. As
portrayed by previous authors [38], densitometric analysis fails
Table  2.  μCT  based  morphometric  indices,  mechanical  results  and  DXA  based  densitometric  values  for  cortical  bone
specimens.
  uCT-based Measurements Mechanical Testing-based Measurements
DXA-based
Measurements
Group
BV/TV
[mm3/mm3]
BS/TV
[mm3/mm3]
Cort.Th
[mm]
App. Density
[g/cm3]
Bone Density
[g/cm3]
Ult. Strain
[mm/mm]
Ult. Strength
[MPa] E [MPa]
Energy to
Failure [kJ] BMC [g]
aBMD [g/
cm2]
CON 0.66 3.27 0.61 741.96 1110.73 0.015 24.35 1583.14 0.12 0.151 0.191
Std Dev 0.02 0.16 0.03 34.34 13.26 0.01 6.08 439.44 0.08 0.011 0.018
OVX 0.62 3.09 0.65 708.89 1098.70 0.02 15.82 869.38 0.12 0.158 0.191
Std Dev 0.02 0.18 0.04 24.38 8.33 0.01 5.85 300.14 0.08 0.013 0.019
VIT-D 0.65 3.27 0.61 729.55 1103.12 0.01 14.40 1268.63 0.07 0.151 0.202
Std Dev 0.04 0.18 0.04 48.64 17.62 0.00 4.39 322.10 0.03 0.006 0.014
P [Time]                   0.001 0.001
P [Group] 0.060 0.040 0.040 0.150 0.150 0.010 0.001 0.001 0.140 0.992 0.003
P*: CON-OVX 0.070 0.080 0.080 0.170 0.170 0.110 0.005 0.001 0.990 0.990 0.990
P*: CON-VIT-D 0.990 0.990 0.990 0.990 0.660 0.920 0.001 0.180 0.280 0.990 0.010
P*:OVX-VIT-D 0.190 0.090 0.100 0.670 0.990 0.010 0.990 0.058 0.230 0.990 0.007
P*: P values from Bonferonni post-hoc analysis
doi: 10.1371/journal.pone.0082709.t002
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its assessment to bone’s quantity, rather than its quality.
µPET/CT Imaging Analysis
Results  of  the  µPET/CT  imaging  aimed  at  quantifying  the
metabolic activity of the bone illustrated that the experimental
groups displayed higher 18FDG uptake values. Several factors
seem  to  play  a  role  in  the  accumulation  of  tracers  in  areas
where microdamage is present, such as increased exposure of
the  mineral  surface  favored  by  the  presence  of  cracks,
increased  blood  flow  and  vascular  permeability,  and  active
osteoblastic  differentiation  and  proliferation  due  to
microdamage  repair  [39,40].  Li  et  al  [36]  were  able  to  show
fairly good correlation values between bone microdamage as
shown  by  µPET/CT  and  histomorphometry  analyses  in
ovariectomized  rat  models.  However,  in  the  latter  case,
microdamage  was  induced  by  fatigue  loading  following
estrogen depletion. Kato et al [41] proposed the use of FDG-
PET analysis to distinguish benign from malignant metastatic
fractures. Curiously, they concluded that acute benign fractures
do not show significant tracer uptake values. Similarly, Schmitz
et al [42] found that acute vertebral fractures originated from
osteoporosis  or  preclinical  osteoporosis,  tended  to  have  no
pathologically increased FDG uptake. On the other hand, Na18F
uptake values showed a different and downward trend in the
experimental groups. In this case, the OVX and VIT-D groups
displayed slightly lower uptake values than those seen in the
control group. Similar results were seen in a study conducted
by Wang et al [43], in which a significant decrease in 18F uptake
was  seen  in  osteoporosis  rat  models  induced  by  excess  of
dexamethasone  phosphate  sodium  injections.  The  same
decreased uptake pattern was evidenced in a human study by
Uchida et al [44]. To our knowledge, analysis of tracer uptake
in vitamin D deficient rats had not been conducted prior to our
study, showing a similar decreased uptake behavior. The tracer
kinetics of this ion is higher at sites of high bone turnover and
remodeling, which leads to interpretation of our results as less
bone formation in the experimental groups [45]. The increased
sensitivity to molecular details gives µPET/CT imaging several
advantages over other methods, mainly the ability to estimate
the activity of osteoblasts and osteoclasts within the tissue, as
well  as  to  distinguish  the  effects  of  mechanical  loading  and
bring  into  evidence  newly-developed  microdamage  [40].
However, its expensive cost - more so when combining both
Figure 4.  DXA-based aBMD changes over the 4 months
study  period  in  CON,  OVX  and  VIT-D  groups  in  both
trabecular  and  cortical  bone  tissues  (*  indicates
significance  between  CON  and  OVX  groups,  **  denotes
significance between CON and VIT-D groups, † indicates
significance between the OVX and VIT-D groups).  
doi: 10.1371/journal.pone.0082709.g004
Table 3. μCT based morphometric indices and DXA based densitometric values for cancellous bone specimens.
  uCT-based Measurements
DXA-based
Measurements
Group
BV/TV
[mm3/
mm3]  
BS/BV
[mm2/
mm3]  
Conn.D.
[1/mm3]   SMI  
Tb.N [1/
mm]  
Tb.Th
[mm]  
Tb.Sp
[mm]  
Tb.1/N
SD  
Tb.Th
SD  
Tb.Sp
SD  
App.
Density
[g/cm3]  
Bone
Density
[g/cm3]   DA  
BMC†
[g]  
aBMD†
[g/cm2]
CON 0.235 34.35 110.26 1.78 4.27 0.075 0.24 0.114 0.02 0.12 316.01 927.83 1.69 0.083 0.212
Std Dev 0.039 6.27 39.04 0.40 0.97 0.01 0.07 0.06 0.005 0.06 34.97 34.46 0.08 0.009 0.021
OVX 0.082 34.69 24.79 2.43 1.28 0.07 0.84 0.61 0.02 0.61 144.04 927.71 1.47 0.075 0.199
Std Dev 0.01 2.15 5.91 0.17 0.33 0.04 0.20 0.17 0.00 0.17 19.28 15.11 0.10 0.006 0.016
VIT-D 0.25 29.31 92.53 1.35 3.79 0.08 0.27 0.14 0.02 0.15 338.07 932.68 1.41 0.081 0.216
Std Dev 0.06 3.09 21.39 0.41 0.83 0.00 0.08 0.07 0.00 0.07 61.33 17.60 0.05 0.007 0.019
P [Time]                           0.001 0.001
P (ANOVA) 0.001 0.020 0.001 0.001 0.001 0.170 0.001 0.001 0.720 0.001 0.001 0.890 0.001 0.001 0.001
P*: CON-
OVX
0.001 0.990 0.001 0.002 0.001 0.990 0.001 0.001 0.990 0.001 0.001 0.990 0.001 0.001 0.001
P*: CON-
VIT-D
0.990 0.059 0.502 0.040 0.590 0.220 0.990 0.990 0.990 0.990 0.810 0.990 0.001 0.440 0.990
P*:OVX-VIT-
D
0.001 0.056 0.001 0.001 0.001 0.540 0.001 0.001 0.990 0.001 0.001 0.990 0.990 0.001 0.001
                  0.99            
P*: P values from Bonferonni post-hoc analysis
† BMD values reported from the last time point
doi: 10.1371/journal.pone.0082709.t003
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used radioisotopes accounts for some of the disadvantages to
be  taken  into  consideration.  Our  findings  call  for  further
research  addressing  the  differences  in  18F  uptake  in
ovariectomized models, as well as potential disparities in such
measurements when inducing micro-damage or not.
DXA Imaging and Mechanical Testing
After  analyzing  different  parameters  using  pathological
models that alter the bone’s structure in many levels, we were
able to identify the effect these changes have in cortical and
cancellous  bone.  Cortical  bone  DXA  analysis  only  showed
differences regarding higher aBMD values in the VIT-D group
as  compared  with  the  OVX  and  CON  groups  (table  2).
Although  we  expected  the  VIT-D  rats  to  show  lower  bone
density values as compared to the control group, our findings
did not portray such results [46]. Nonetheless, these findings,
as  well  as  those  obtained  from  µCT  analysis,  suggest  that
there is minimal compromise of cortical bone when affected by
disease states addressed in our study. Although not statistically
significant,  specimens  from  the  OVX  group  showed  slightly
higher cortical thickness values when compared to the other
two groups. This could be explained by a small compensatory
effect occurring in cortical bone as a result of the pathological
changes  taking  place  in  the  trabecular  tissue  [19,47].  As
expected,  mechanical  testing-based  measurements  showed
lower ultimate strength values in the experimental groups as
compared to the control. Yet, no differences in energy to failure
were observed across groups, and only the OVX specimens
showed significantly lower tensile moduli. These results from
cortical bone analysis support findings from one of our previous
works  [19],  which  showed  that  DXA  and  μCT  imaging  were
unable to show important changes in the material, structural,
and  mechanical  properties  of  femoral  cortical  bone  in  the
ovariectomized model, at least 7 weeks following ovariectomy.
Similarly,  the  inconsistency  of  densitometric  measurements
and mechanical testing parameters attest to the interaction of
multiple  aspects  that  govern  the  structural  and  mechanical
Figure 5.  Body mass changes over the 4 months study
period  in  CON,  OVX  and  VIT-D  groups  (*  indicates
significance  between  CON  and  OVX  groups,  **  denotes
significance between CON and VIT-D groups, † indicates
significance between the OVX and VIT-D groups).  
doi: 10.1371/journal.pone.0082709.g005
properties of bone and its concomitant changes in the tissue’s
biomechanics  when  affected  by  different  pathological
processes. Skeletal diseases cause fragile bones affecting its
structure  through  different  mechanisms  [37].  While
osteomalacia results in weak and ductile bones, osteoporosis
reduces  bone  formation,  both  resulting  in  reduced  ultimate
strength. Following this analysis, it is evident how the traditional
non-invasive densitometric and CT imaging techniques failed
equally  to  detect  the  strength  differences  seen  in  cortical
bones’  mechanical  testing  across  the  three  groups.
Nonetheless, this was not the case when assessing cancellous
bone.
DXA-based measurements only picked up significantly lower
BMC and aBMD values in the OVX group when compared to
the VIT-D and CON groups. Our measurements failed to detect
differences  when  comparing  CON  with  the  VIT-D  group.
However, differences between the morphometric indices of the
three  groups  were  identified  by  µCT  imaging  and  analysis.
Bone volume fraction, connectivity density, trabecular number
and  apparent  density  values  were  lower  in  the  OVX  group
when  compared  to  the  other  two  groups,  yet  there  were  no
differences between the latter. As for trabecular spacing, rats
from  the  ovariectomized  group  showed  significantly  higher
values  as  compared  to  the  VIT-D  and  control  groups.  The
obtained values coincide with those portrayed by Dempster et
al  [48],  who  explained  changes  in  cancellous  bone  due  to
estrogen deficiency by the osteoclast perforation of trabecular
plates, resulting in decreased connectivity. In that case, which
was also seen in this study, no generalized trabecular thinning
ensued,  thus  no  differences  in  trabecular  thickness  values
were seen among either of the groups. As for the degree of
anisotropy, those allocated to the CON group showed greater
values  than  those  from  the  experimental  groups.  Thus,
specimens from the OVX and VIT-D groups moved towards a
more isotropic yet undesirable state, detrimental to the multi-
axial loading of bone during daily activities. SMI values differed
significantly  across  the  three  groups,  with  OVX  showing  the
highest  measurement,  followed  by  CON  and  then  the  VIT-D
group.  This  measurement  allows  us  to  quantify  the
characteristic form of a three-dimensional structure in terms of
the amount of plates and rods composing the structure [49].
Disregarding  the  physical  dimensions,  ideal  plate  and  rod
structures  will  show  values  of  0  and  3,  respectively.
Consequently, for a structure with both plates and rods in equal
proportions,  the  value  will  fall  in  the  middle  of  these  values.
Cancellous  bone  from  the  OVX  and  VIT-D  groups  moved  in
opposite directions, the former showing a predominantly rod-
like pattern, whereas the latter more of a plate-like one. The
increased  values  of  both  trabecular  spacing  and  SMI  in  the
ovariectomized rats suggests the occurrence of perforation of
the  trabecular  plates,  as  shown  in  prior  transmenopausal
human studies by Akhter et al [50].
There  is  a  consensus  that  ovariectomy  causes  rapid
changes in cancellous bone, while changes in cortical bone are
much  slower  [48,51].  Also,  estrogen  deficiency  does  not
usually  cause  mechanical  weakening  of  cortical  bone  [52].
These findings support the results seen in our study, confirming
that  ovariectomy  induces  high  bone  turnover  that  affects
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Interestingly,  although  the  OVX  group  showed  lower  aBMD
values  when  compared  to  the  controls,  the  trend  shows
somewhat an increase over time. We think this may be due to
the acute changes seen following the abrupt estrogen depletion
that  induces  a  rapid  and  sudden  change  in  aBMD  that  later
stabilizes due to homeostatic adaptive changes made by the
tissue in order to find equilibrium. Although we were not able to
detect bone mineral density loss in the VIT-D group, a higher
bone turnover and decreased bone mineralization is expected
in the presence of vitamin D deficiency [53].
Conclusion
We comprehensively assessed the differences across bones
affected  with  different  altered  skeletal  states  induced  by
ovariectomy and vitamin D deficient diets using traditional as
well as novel diagnostic modalities. Our findings further justify
the  inaccuracy  of  densitometric-based  parameters  in
differentiating  metabolic  bone  diseases.  However,  although
beyond the scope of our study, its usefulness in the diagnosis
of metabolic bone diseases should not be disregarded. DXA is
still  the  most  widely  used  method  that  has  among  its
advantages the ability to obtain measurements at or close to a
specific site of interest (commonly lumbar spine and proximal
femur) [54,55]. Also, it has been recognized as being relatively
less  complex  and  inexpensive  when  compared  to  the  other
methods  discussed  in  the  present  work  [17].  However,  DXA
measures  the  average  bone  mineral  content  in  a  two-
dimensional projected area with low spatial resolution, thus it
cannot  differentiate  whether  the  changes  occur  in  the  bone
microstructure  or  bone  tissue  density.  Another  known
drawback  of  DXA  is  the  possibility  of  overestimating  aBMD
values in posteroanterior measurements of the lumbar spine,
due to the presence of typical degenerative changes seen in
the elderly. Determination of volumetric bone mineral density in
any part of the skeletal structure accounts for one of the main
contrast points between QCT and DXA. Also, QCT allows for
the  possibility  of  assessing  cortical  and  cancellous  bone
separately [56]. Although QCT has not proven to be superior to
anteroposterior  spinal  DXA  measurements,  it  eliminates
artifacts  from  soft  tissue  and  posterior  elements  previously
mentioned that may overestimate some of the obtained values
[57].  On  the  downside,  the  precision  of  QCT-derived  BMD
measurements  depends  in  part  of  the  repositioning  of  the
patient,  as  well  as  in  the  size  and  shape  of  the  region  of
interest.  Also,  the  accuracy  of  such  technique  is  limited  by
beam-hardening and partial volume averaging [58].
As  osteomalacia  is  characterized  by  impaired  bone
mineralization, the use of densitometric analyses may lead to
misinterpretation  of  the  condition  as  osteoporosis  [59].  In
contrast, CT imaging in combination with the PET component
certainly provides an accurate three-dimensional measurement
of  the  changes  in  both  bone  tissue  mineral  density,
microstructure and metabolic activity for cortical and cancellous
bone.
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